Skip to main content
OpenTrials
Completed

NCT Number: NCT02664129

Video as a Tool to Improve Insight in Schizophrenia

The deficit of awareness of pathology (or insight) is a common symptom in patients with schizophrenia and has a negative impact on the prognosis of the disease. Current treatments aren't effective enough on this symptom (Pijnenbord et al., 2013).

Previous studies have shown a positive impact of videos of patients themselves on insight but they lacked power. This technique needs more investigation. The study aims to improve the patient's awareness of pathology with a video of themselves recorded in the acute phase of their illness. Patients will watch this video after clinical stabilization. This is a randomized controlled and single blinded trial. A population of 60 patients (30 in each group) will be included. The impact on the insight, symptomatology, treatment adherence and functional remission will be evaluated.

The video of patient is useful for a personalized clinical follow-up. Its use for therapeutic purposes would be innovative and could be extended to other applications in psychiatry, especially as this tool is readily available.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospital of Montpellier, Montpellier, France

Loading trial locations.

About this study

In everyday practice in psychiatry, some interviews are filmed in order to follow the clinical course and for educational purposes. But the videos are not used as a therapeutic tool for patients. This research project focuses on the therapeutic potential of these videos and particularly on the awareness of patients of their disorder (insight). Patients hospitalized for decompensation of their schizophrenic pathology will be filmed during structured interviews. After clinical stabilization patients will be proposed to participate to this trial. A group of patients (G1) will watch the video recorded in the acute phase of their illness. A control group (G2) will have a usual care without video or specific therapy. 48 hours after, the clinical impact et the evolution of insight of patients will be evaluated. Then follow-up visits will also be provided at one and four months with the same clinical evaluation, plus an evaluation of treatment adherence and functional remission. This study also includes qualitative interviews for group 1 after watching the video to explore the experience of patients in this situation of self-confrontation. The autobiographical memory will also be studied in this protocol. Tolerance of this experience will be assessed by a monitoring of emotions, specifically depressive affects and suicidal ideation. Adverse events will be reported and patients will always have the access to a psychiatrist if necessary.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with a diagnosis of schizophrenia or schizoaffective disorder according to the DSM 5
  • Age between 18 and 65 years
  • Patients initially hospitalized for acute decompensation of their schizophrenia or schizoaffective disorder according to the medical records and any medical certificates
  • Patients who agreed to be filmed during a standardized interview at screening (in acute decompensation phase of the disease at the beginning of hospitalization)
  • Clinical state compatible with the therapeutic experience and obtaining consent with a score on the scale of PANSS positive symptoms of less than 24

Exclusion criteria

  • Mental impairment moderate to severe
  • Central nervous system disease or severe head trauma
  • Chronic alcohol dependence
  • Patients hospitalized for a social problem or otherwise, without acute decompensation of their schizophrenia or schizoaffective disorder as assessed by the referring psychiatrist
  • Patients deprived of liberty by judicial decision
  • Pregnant and breastfeeding women

Treatment and study plan

Video self-observation

Other

Patients will watch the video of them in acute decompensation phase then they will be asked about their emotions, their understanding and awareness of mental illness

Other names: Group 1

Non Self video observation

Other

Patients will not watch the video of them in acute decompensation phase.

Other names: Group 2

Primary outcomes

  1. Unawareness of Mental Disorder (SUMD)

    Time frame: 48 hours

    Scale to assess Unawareness of Mental Disorder (SUMD)

Secondary outcomes

  1. Insight

    Time frame: 48 hours

    Birchwood Insight Scale

  2. Cognitif Insight

    Time frame: 48 hours

    Beck Cognitive Insight Scale

  3. Positive Symptom

    Time frame: 48 hours

    Positive and Negative Symptom Scale

  4. Negative Symptom

    Time frame: 48 hours

    Positive and Negative Symptom Scale

  5. Depression

    Time frame: 48 hours

    Calgary Depression Scale for Schizophrenia

  6. Autobiographical Memory

    Time frame: 48 hours

    Autobiographical Memory Test

  7. Medication Adherence

    Time frame: 48 hours

    Medication Adherence Rating Scale

  8. Functional Remission (FROGS scale)

    Time frame: 48 hours

    Evaluation of quality of daily life

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Collaborators

  • Centre Hospitalier Universitaire de Nīmes

Registry information

Official study title

Video Self-observation as a Therapeutic Tool for Improving the Insight of Patients With Schizophrenia Disorders

Acronym: VideoInsight

Important dates

Study start
2015
Primary completion
2018
Study completion
2018
First posted
Jan 26, 2016
Registry last updated
Sep 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.